Despite another best recognized for its lipid actions, active ingredient retinal benefits of fenofibrate in the Another medical and ACCORD trials Xafenor include appear to Xafenor due to quantitative lipid improvements. Periodic monitoring of red and white blood cell counts is recommended during the first 12 months of fenofibrate administration. It is not known fenofibrate passes into breast milk. Taking fenofibrate and certain cholesterol drugs called bile acid sequestrants may make it harder for your body to absorb fenofibrate.
Possible side effects of Xafenor include:
Xafenor is used to treat diseases such as: Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia Type IV, Elevated VLDL, Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL, Hypertriglyceridemia.
The recommended dosage for children more than 40kg is one 150mg tablet twice daily.